Navigation Links
Nycomed US Inc. Names Brian A. Markison as Chief Executive Officer
Date:8/1/2011

MELVILLE, N.Y., Aug. 1, 2011 /PRNewswire/ -- Nycomed US Inc. ("Nycomed US") today announced the appointment of Brian A. Markison as President and Chief Executive Officer and member of the Board for what will be the newly created standalone corporation created following the closing of the acquisition of Nycomed A/S by Takeda Pharmaceuticals.  

The Company also appointed Jeff Bailey to the newly created position of Chief Operating Officer, and John Golubieski as the Chief Financial Officer.  

The Company noted that Mr. Markison's more than 30 years of experience in the pharmaceutical industry will be instrumental in driving future growth, which Nycomed US expects to achieve organically as well as through acquisitions, product partnerships and in-licensing opportunities.  

Mr. Markison formerly served as Chairman and Chief Executive Officer of King Pharmaceuticals, which he joined as Chief Operating Officer before being promoted to President and CEO in 2004 and elected to Chairman in 2007.  Prior to King, Mr. Markison held various senior leadership positions at Bristol-Myers Squibb, including President of Oncology / Virology and Oncology Therapeutics Network; President – Neuroscience / Infectious Disease and Dermatology; and Senior Vice President, Operational Excellence and Productivity.  Mr. Markison serves on the Board of Directors of Immunomedics, Inc. and Rosetta Genomics, Ltd., where he also serves as Board Chairman.  Mr. Markison also serves on the Board of Directors for the Komen Foundation for South / Central New Jersey and on the Board of Trustees for the Pennington School. Mr. Markison holds a BS degree from Iona College.

Mr. Markison said, "I am delighted, along with Jeff and John, to join the team at Nycomed US.  This is an exciting time for the company because we have the opportunity to grow aggressively and forge our future as an independent entity.  Jeff and John are great addi
'/>"/>

SOURCE Nycomed US Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Nycomeds Daxas(R) Shows Encouraging Preliminary Results in Phase III COPD Studies
2. Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US
3. Axial Biotech Names New VP of Reimbursement and Regulatory Affairs
4. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
5. Genstruct Names Louis Latino VP of Sales
6. Codexis Names Vice President, Intellectual Property
7. New England Peptide Names Director of Chemical Development
8. Horizon Therapeutics Names Robert J. De Vaere Executive Vice President and Chief Financial Officer
9. Board of Directors of Milestone Scientific Names Joseph DAgostino Chief Financial Officer
10. PercSys Names David Auth and Howard Palefsky to Its Board of Directors
11. Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... Immune Pharmaceuticals Inc., or "Immune" (NASDAQ: ... elected Rene-Pierre Azria as a Director and ... oversight on strategic and financial transactions. Mr. Azria will ... Compensation Committee and the Corporate Governance and Nomination Committee. ... have a long-time interest in Life Sciences and in ...
(Date:4/21/2015)... , April 21, 2015  Tute Genomics, a leading ... of Josh Forsythe as VP of Marketing. Mr. ... witnessed a significant expansion in its commercial operations over the ... " Josh Forsythe is a tremendous addition ... MD MBA, CEO of Tute Genomics. "Josh,s vast experience commercializing ...
(Date:4/21/2015)... Limited (ASX:NRT; NASDAQ: NVGN ) ("Company" or "Novogen"), ... entered into definitive agreements today to issue approximately ... 6-month option and half of one attaching 5-year ... investors in the United States ... proceeds of approximately AU$15,500,000 ("Placement"). The closing of ...
(Date:4/21/2015)... SILVER SPRING, Md. and RESEARCH ... -- United Therapeutics Corporation (NASDAQ: UTHR ) announced ... financial results before market open on Tuesday, April 28, ... teleconference on Tuesday, April 28, 2015, at 9:00 a.m. ... with international callers dialing 1-970-315-0533.  A rebroadcast of the ...
Breaking Biology Technology:Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee 2Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee 3Immune Board Elects Rene-Pierre Azria A Director And Chair Of The Transaction Committee 4Tute Genomics Continues Expansion of Genomic Medicine Commercial Operations; Appoints Josh Forsythe as New VP of Marketing 2Tute Genomics Continues Expansion of Genomic Medicine Commercial Operations; Appoints Josh Forsythe as New VP of Marketing 3Tute Genomics Continues Expansion of Genomic Medicine Commercial Operations; Appoints Josh Forsythe as New VP of Marketing 4Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 2Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 3Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 4Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 5Novogen Conducts Private Placement and Announces Rights Offering to Shareholders 6
... , , MENLO ... California-based partners hosted the California Bioscience Business Roundtable (BBR) event at ... featured Sam Youngman, the White Correspondent for The Hill newspaper, who ... debate in Washington, D.C. , , Bioscience represents ...
... , , The statement below is from Pete ... Company, its employees and its Board of Directors. , , ... across a remarkably broad spectrum of issues. Foremost among them was his ... , , He was a tireless advocate for patients, rights ...
... 11%, - Strong Research and Investment Effort, - Positive net Financial Position, - Annual ... Saporta approved the 2009 half year financial statements: , , In million Euros ... ... Sales 87.0 ...
Cached Biology Technology:California Life Science, Business, and Economic Development Experts Discuss California's Bioscience Future 2Boston Scientific Statement on the Passing of Senator Edward Kennedy 2STALLERGENES: 1st Half-Year 2009: Performance Ahead of Expectations 2STALLERGENES: 1st Half-Year 2009: Performance Ahead of Expectations 3STALLERGENES: 1st Half-Year 2009: Performance Ahead of Expectations 4
(Date:3/31/2015)... --  Guidepoint , a leading global research services firm, ... TRACKER, part of the Guidepoint TRACKER suite ... device and therapeutics markets. The Post-Surgical Pain Management TRACKER ... share, and adoption rates across three major modalities used ... The Post-Surgical Pain Management TRACKER will provide length ...
(Date:3/24/2015)... DUBLIN , Mar. 24, 2015 Research and ... addition of the "Global Iris Recognition Market 2015-2019" ... forecast the Global Iris Recognition market to grow at ... This report covers the present scenario and ... for the period 2015-2019. To calculate the market size, ...
(Date:3/24/2015)... , March 24, 2015   Crossmatch ™, ... today announced that its U.are.U ® 4500 ... Goorin Bros . to achieve PCI compliance ... secures access to the POS terminal, protecting the ... of data breaches. With one-third ...
Breaking Biology News(10 mins):Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2
... Bethesda, MD This FASEB Science Research Conference brings ... define how the conformations of cellular proteins are achieved ... aberrant protein conformations arise. Specific sessions ... pathways, the mechanisms of action of molecular chaperones, pathways ...
... JUPITER, FL, January 22, 2013 How aging affects ... that makes it more difficult to treat a range ... A new study from the Florida campus of The ... affects the brain,s neural circuitry, in some cases significantly ...
... accurate information about endangered bats, birds and insects. A new ... revealed many previously unknown and highly valuable details about bats. ... in tents for several days with binoculars and infrared cameras ... system, which for two months has continuously recorded bat activity ...
Cached Biology News:Scripps Florida scientists offer new insight into neuron changes brought about by aging 2New monitoring technique reveals endangered animals 2New monitoring technique reveals endangered animals 3
Mouse monoclonal antibody to QPCT - glutaminyl-peptide cyclotransferase (glutaminyl cyclase)...
... MSY2/YBOX2 ( Abpromise for all ... Synthetic peptide derived from a ... human YBX2. (Note: the exact ... Entrez Gene ...
Rabbit polyclonal to YANK2 ( Abpromise for all tested applications). Antigen: A KLH conjugated synthetic peptide selected within aa 300~400 (C terminal region) of human YANK2. Entrez Gene ID:...
Certified by the Biological Stain Commission. For staining fresh peripheral blood smears and blood parasites....
Biology Products: